Chad vs Cote d'Ivoire: The number of people with susceptibility test result for rifampicin
Chad
7,424
in 2021
Cote d'Ivoire
8,494
in 2021
Chad rank
26th
Cote d'Ivoire rank
25th
The number of people with susceptibility test result for rifampicin over time
- Chad
- Cote d'Ivoire
How they compare
Cote d'Ivoire currently reports 8,494 against 7,424 in Chad, a difference of 1,070.
That makes Cote d'Ivoire's figure about 1.1 times Chad's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Cote d'Ivoire ahead.
Chad ranks 26th and Cote d'Ivoire ranks 25th of 155 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Cote d'Ivoire in 1.
Head to head by decade
| Decade | Chad | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 726.67 | 3,175 | 2,448 | Cote d'Ivoire |
| 2020s | 5,036 | 4,890 | 146.5 | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chad or Cote d'Ivoire?
- Cote d'Ivoire, at 8,494 against 7,424 in Chad as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chad and Cote d'Ivoire?
- 1,070, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Chad and Cote d'Ivoire?
- 5 years are reported by both, from 2017 to 2021.
- How do Chad and Cote d'Ivoire rank globally for the number of people with susceptibility test result for rifampicin?
- Chad ranks 26th and Cote d'Ivoire ranks 25th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.